20th Annual Pain Therapeutics Summit
Hosted by Arrowhead Publishers, LLC
- 28 – 29 September 2026
- Hilton San Francisco Airport Bayfront, Burlingame, United States of America
- Health SciencesPharmacy & Pharmaceutical SciencesMedical & Health Sciences
Let others know you'll be there. This does not register you for the event.
Registration
Event has endedRegistration is handled by the organiser
Fees are listed on this page
View registration detailsKey facts
20th Annual Pain Therapeutics Summit is a summit held 28 – 29 September 2026 in Hilton San Francisco Airport Bayfront, Burlingame, United States of America, organised by Arrowhead Publishers, LLC.
- Dates:
- 28 – 29 September 2026
- Format:
- In person
- Venue:
- Hilton San Francisco Airport Bayfront, Burlingame, United States of America
- Subjects:
- Pharmacy & Pharmaceutical Sciences, Medical & Health Sciences
- Organiser:
- Arrowhead Publishers, LLC
- Official website:
- paintherapeuticsummit.com
The 20th Annual Pain Therapeutics Summit gathers professionals from biotech, pharmaceuticals, academia, government, clinical research organizations, and investment sectors to examine current breakthroughs in pain research and translational science. Held over two days in the San Francisco Bay Area, the event provides a collaborative platform to discuss non-opioid drug development, novel mechanisms of action, biomarkers, and precision medicine approaches aimed at enhancing patient care for acute and chronic conditions.
Topics
- Clinical Trial Study Design
- Trends in Pain Research
- Novel Pain Drug Targets
- Genetic Components of Pain
- Emerging Pain Drug Candidates
- Pain Biomarkers
Programme highlights
View full programmeSpeakers
View all 40 speakersStanford University School of Medicine
Advancing Therapeutic Strategies for Trigeminal NeuralgiaPSPP, Division of Translational Research, NINDS, National Institutes of Health
University of California San Francisco
Advancing Therapeutic Strategies for Trigeminal NeuralgiaThe University of California San Francisco
Innovating Trial Design in a Double-Masked, Randomized Trial of Psilocybin for Chronic Low Back PainThe University of Texas MD Anderson Cancer Center & The University of Southern California
The NIH Pain Therapeutics Development Program (PTDP)PPD, part of Thermo Fisher
Reshaping the Way we Think and Conduct Clinical Trials in Chronic Pain
Organiser and contact
Host organisation
Arrowhead Publishers, LLCContact
- Event secretary:
- John Waslif
- Email:
- [email protected]
Advertisement
Related events
- 2026 ACAAI Annual Scientific MeetingPhoenix, United States of America12–16 Nov 2026
- ObesityWeek 2026National Harbor, United States of America14–17 Nov 2026
- U.S Biotech Day 2026Philadelphia, United States of America16–17 Nov 2026
- Biomarker Operations & Biospecimen Management SummitBoston, United States of America16–17 Nov 2026
- 19th Clinical Trials on Alzheimer's Disease (CTAD)Boston, United States of America16–19 Nov 2026
- 8th TIL Therapies Summit 2026Boston, United States of America17–19 Nov 2026